当前位置:
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Impact of HCV eradication on recurrence pattern and long-term outcomes in patients with HCV-related hepatocellular carcinoma undergoing radiofrequency ablation
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-08-07 , DOI: 10.1111/apt.18199 Kuo-Cheng Wu, I-Cheng Lee, Chen-Ta Chi, Chien-An Liu, Nai-Chi Chiu, Shao-Jung Hsu, Pei-Chang Lee, Chi-Jung Wu, Jiing-Chyuan Luo, Ming-Chih Hou, Yi-Hsiang Huang
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-08-07 , DOI: 10.1111/apt.18199 Kuo-Cheng Wu, I-Cheng Lee, Chen-Ta Chi, Chien-An Liu, Nai-Chi Chiu, Shao-Jung Hsu, Pei-Chang Lee, Chi-Jung Wu, Jiing-Chyuan Luo, Ming-Chih Hou, Yi-Hsiang Huang
The benefits of HCV eradication on distinct recurrence patterns and long-term hepatic outcomes in patients with hepatocellular carcinoma (HCC) undergoing radiofrequency ablation (RFA) remain uncertain. This study aims to assess the impact of HCV eradication on HCC recurrence patterns and long-term hepatic outcomes after RFA and to identify predictors of recurrence in patients achieving sustained virological response (SVR).
中文翻译:
根除 HCV 对接受射频消融术的 HCV 相关肝细胞癌患者复发模式和远期预后的影响
根除 HCV 对接受射频消融术 (RFA) 的肝细胞癌 (HCC) 患者不同复发模式和长期肝脏结局的益处仍不确定。本研究旨在评估根除 HCV 对 RFA 后 HCC 复发模式和长期肝脏结局的影响,并确定达到持续病毒学反应 (SVR) 的患者复发的预测因子。
更新日期:2024-08-07
中文翻译:
根除 HCV 对接受射频消融术的 HCV 相关肝细胞癌患者复发模式和远期预后的影响
根除 HCV 对接受射频消融术 (RFA) 的肝细胞癌 (HCC) 患者不同复发模式和长期肝脏结局的益处仍不确定。本研究旨在评估根除 HCV 对 RFA 后 HCC 复发模式和长期肝脏结局的影响,并确定达到持续病毒学反应 (SVR) 的患者复发的预测因子。